Tapewire

Nasdaq · USD

NXL

Nexalin Technology, Inc.

Export transactions ↓
Tapewire entity
8197
SEC CIK
0001527352
Parsed reports
57

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 19, 2025 Filed Dec 23, 2025 09:41 UTC GrantStock Option (right to buy)* · Derivative 100,000 $0.00 Strike: $0.83 $0.00
Disclosure

SEC source: 0001829126-25-010254 · ownership.xml · derivative · entry 1

Van Fleet Justin · CIK 0002080067 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 230,435

Underlying: Common Stock · 100,000 shares

Expires 2030-12-19

Read SEC document
December 19, 2025 Filed Dec 23, 2025 09:40 UTC
Shelton Carolyn HambySr. VP - Quality - Regulatory
GrantStock Option (right to buy)* · Derivative 100,000 $0.00 Strike: $0.83 $0.00
Disclosure

SEC source: 0001829126-25-010252 · ownership.xml · derivative · entry 1

Shelton Carolyn Hamby · CIK 0002053473 · Sr. VP - Quality - Regulatory

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 210,620

Underlying: Common Stock · 100,000 shares

Expires 2030-12-19

Read SEC document
December 19, 2025 Filed Dec 23, 2025 14:41 UTC
White MarkDirector · CEO
GrantStock Option (right to buy)* · Derivative 1,000,000 $0.00 Strike: $0.83 $0.00
Disclosure

SEC source: 0001829126-25-010255 · ownership.xml · derivative · entry 1

White Mark · CIK 0001916493 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,387,024

Underlying: Common Stock · 1,000,000 shares

Expires 2030-12-19

Read SEC document
December 19, 2025 Filed Dec 23, 2025 14:40 UTC
Hu BenDirector
GrantStock Option (right to buy)* · Derivative 100,000 $0.00 Strike: $0.83 $0.00
Disclosure

SEC source: 0001829126-25-010251 · ownership.xml · derivative · entry 1

Hu Ben · CIK 0001916504 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2030-12-19

Read SEC document
December 19, 2025 Filed Dec 23, 2025 14:41 UTC
Owens DavidDirector · Chief Medical Officer
GrantStock Option (right to buy)* · Derivative 1,000,000 $0.00 Strike: $0.83 $0.00
Disclosure

SEC source: 0001829126-25-010253 · ownership.xml · derivative · entry 1

Owens David · CIK 0001916664 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,484,809

Underlying: Common Stock · 1,000,000 shares

Expires 2030-12-19

Read SEC document
December 19, 2025 Filed Dec 23, 2025 14:40 UTC
Kazden AlanDirector
GrantStock Option (right to buy)* · Derivative 100,000 $0.00 Strike: $0.83 $0.00
Disclosure

SEC source: 0001829126-25-010250 · ownership.xml · derivative · entry 1

Kazden Alan · CIK 0001917765 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 362,500

Underlying: Common Stock · 100,000 shares

Expires 2030-12-19

Read SEC document
September 29, 2025 Filed Sep 30, 2025 17:02 UTC
OSSER LEONARD10% owner
GrantCommon Stock 83,333 $0.00 $0.00
Disclosure

SEC source: 0001829126-25-007778 · ownership.xml · nonDerivative · entry 1

OSSER LEONARD · CIK 0001188354 · 10% owner

Elson Marilyn · CIK 0001916491 · Spouse

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,618,577

F1 · balance_after: Includes shares that Reporting Person owns with spouse Leonard Osser and for which Reporting Person has shared voting and dispositive power with spouse. Form 4 filed as joint ownership filing

Read SEC document
September 29, 2025 Filed Sep 30, 2025 21:01 UTC
Owens DavidDirector · Chief Medical Officer
GrantCommon stock 36,459 $0.00 $0.00
Disclosure

SEC source: 0001829126-25-007777 · ownership.xml · nonDerivative · entry 1

Owens David · CIK 0001916664 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 191,252

Read SEC document
September 29, 2025 Filed Sep 30, 2025 21:00 UTC
Hu BenDirector
GrantCommon stock 36,459 $0.00 $0.00
Disclosure

SEC source: 0001829126-25-007776 · ownership.xml · nonDerivative · entry 1

Hu Ben · CIK 0001916504 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 377,095

F1 · balance_after: Includes 372,929 shares held by Mr. Hu, 3,582 shares held jointly by Mr. Hu and Amy Lun Hu, his spouse, and 584 shares held jointly by Mr. Hu and David D. Hu, his son.

Read SEC document
September 29, 2025 Filed Sep 30, 2025 21:00 UTC
Kazden AlanDirector
GrantCommon stock 36,459 $0.00 $0.00
Disclosure

SEC source: 0001829126-25-007775 · ownership.xml · nonDerivative · entry 1

Kazden Alan · CIK 0001917765 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Owned by Alan and Natalie Kazden Family Trust

Disclosed balance after: 119,590

F1 · ownership.nature: Reporting Person has dispositive and voting control of the shares.

Read SEC document
September 12, 2025 Filed Sep 12, 2025 17:09 UTC
Shelton Carolyn HambySr. VP - Quality - Regulatory
GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $2.95 $0.00
Disclosure

SEC source: 0001829126-25-007374 · ownership.xml · derivative · entry 1

Shelton Carolyn Hamby · CIK 0002053473 · Sr. VP - Quality - Regulatory

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,620

Underlying: Common Stock · 20,000 shares

Expires 2029-12-27

F1 · derivative.exercise_date: The reporting person was granted an option to purchase 20,000 shares of common stock. The option vests in three equal annual installments for each of the annual periods ending December 27, 2025, 2026 and 2027.

Read SEC document
September 12, 2025 Filed Sep 12, 2025 21:08 UTC
Owens DavidDirector · Chief Medical Officer
GrantStock Option (right to buy) · Derivative 100,000 $0.00 Strike: $0.96 $0.00
Disclosure

SEC source: 0001829126-25-007373 · ownership.xml · derivative · entry 2

Owens David · CIK 0001916664 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,484,809

Underlying: Common Stock · 100,000 shares

Expires 2030-08-29

Read SEC document
September 12, 2025 Filed Sep 12, 2025 21:08 UTC
Owens DavidDirector · Chief Medical Officer
GrantStock Option (right to buy) · Derivative 203,125 $0.00 Strike: $0.96 $0.00
Disclosure

SEC source: 0001829126-25-007373 · ownership.xml · derivative · entry 1

Owens David · CIK 0001916664 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,384,809

Underlying: Common Stock · 203,125 shares

Expires 2030-08-29

Read SEC document
September 10, 2025 Filed Sep 12, 2025 12:58 UTC
Elson Marilyn10% owner
OSSER LEONARD10% owner · Spouse
SaleCommon Stock Warrants · Derivative 23,150 $0.02 Strike: $4.15 $402.81
Disclosure

SEC source: 0001829126-25-007350 · ownership.xml · derivative · entry 1

Elson Marilyn · CIK 0001916491 · 10% owner

OSSER LEONARD · CIK 0001188354 · 10% owner · Spouse

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,850

Underlying: Common Stock · 23,150 shares

Expires 2025-09-19

Read SEC document
July 17, 2025 Filed Jul 21, 2025 12:35 UTC
Elson Marilyn10% owner
GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $1.15 $0.00
Disclosure

SEC source: 0001829126-25-005220 · ownership.xml · derivative · entry 6

Elson Marilyn · CIK 0001916491 · 10% owner

OSSER LEONARD · CIK 0001188354 · Spouse

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 436,000

Underlying: Common Stock · 30,000 shares

Expires 2030-07-17

Read SEC document
July 17, 2025 Filed Jul 21, 2025 12:35 UTC
Elson Marilyn10% owner
GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $1.15 $0.00
Disclosure

SEC source: 0001829126-25-005220 · ownership.xml · derivative · entry 5

Elson Marilyn · CIK 0001916491 · 10% owner

OSSER LEONARD · CIK 0001188354 · Spouse

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 406,000

Underlying: Common Stock · 30,000 shares

Expires 2030-07-17

Read SEC document
July 17, 2025 Filed Jul 21, 2025 12:35 UTC
Elson Marilyn10% owner
GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $1.15 $0.00
Disclosure

SEC source: 0001829126-25-005220 · ownership.xml · derivative · entry 4

Elson Marilyn · CIK 0001916491 · 10% owner

OSSER LEONARD · CIK 0001188354 · Spouse

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 376,000

Underlying: Common Stock · 30,000 shares

Expires 2030-07-17

Read SEC document
July 17, 2025 Filed Jul 21, 2025 12:35 UTC
Elson Marilyn10% owner
GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $1.15 $0.00
Disclosure

SEC source: 0001829126-25-005220 · ownership.xml · derivative · entry 3

Elson Marilyn · CIK 0001916491 · 10% owner

OSSER LEONARD · CIK 0001188354 · Spouse

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 346,000

Underlying: Common Stock · 30,000 shares

Expires 2030-07-17

Read SEC document
July 17, 2025 Filed Jul 21, 2025 12:35 UTC
Elson Marilyn10% owner
GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $1.15 $0.00
Disclosure

SEC source: 0001829126-25-005220 · ownership.xml · derivative · entry 2

Elson Marilyn · CIK 0001916491 · 10% owner

OSSER LEONARD · CIK 0001188354 · Spouse

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 316,000

Underlying: Common Stock · 30,000 shares

Expires 2030-07-17

Read SEC document
July 17, 2025 Filed Jul 21, 2025 12:35 UTC
Elson Marilyn10% owner
GrantStock Option (right to buy) · Derivative 150,000 $0.00 Strike: $1.15 $0.00
Disclosure

SEC source: 0001829126-25-005220 · ownership.xml · derivative · entry 1

Elson Marilyn · CIK 0001916491 · 10% owner

OSSER LEONARD · CIK 0001188354 · Spouse

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 286,000

Underlying: Common Stock · 150,000 shares

Expires 2030-07-17

Read SEC document
March 12, 2025 Filed Mar 13, 2025 16:52 UTC
Shelton Carolyn HambySr. VP - Quality, Regulatory
PurchaseCommon Stock 6,000 $2.20 $13,200.00
Disclosure

SEC source: 0001829126-25-001766 · ownership.xml · nonDerivative · entry 1

Shelton Carolyn Hamby · CIK 0002053473 · Sr. VP - Quality, Regulatory

10b5-1 filing: No plan indicated

Ownership: Indirect · By Husband

Disclosed balance after: 30,000

F1 · balance_after: Includes 24,000 shares owned directly by Reporting Person.

Read SEC document
February 26, 2025 Filed Feb 27, 2025 21:33 UTC
Owens DavidDirector · Chief Medical Officer
GrantStock Option (right to buy) · Derivative 125,000 $0.00 Strike: $2.95 $0.00
Disclosure

SEC source: 0001829126-25-001254 · ownership.xml · derivative · entry 3

Owens David · CIK 0001916664 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 919,184

Underlying: Common Stock · 125,000 shares

Expires 2029-12-27

Read SEC document
February 26, 2025 Filed Feb 27, 2025 21:33 UTC
Owens DavidDirector · Chief Medical Officer
GrantStock Option (right to buy) · Derivative 654,363 $0.00 Strike: $0.89 $0.00
Disclosure

SEC source: 0001829126-25-001254 · ownership.xml · derivative · entry 2

Owens David · CIK 0001916664 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 794,184

Underlying: Common Stock · 654,363 shares

Expires 2034-06-30

F1 · derivative.exercise_date: The option vests in three equal annual installments based on the satisfaction of certain performance criteria for each of the annual periods ending June 30, 2024, 2025 and 2026. The performance criteria for the period ending June 30, 2024 were met, resulting in the vesting of options to purchase 218,121 shares.

Read SEC document
February 26, 2025 Filed Feb 27, 2025 21:33 UTC
Owens DavidDirector · Chief Medical Officer
GrantStock Option (right to buy) · Derivative 139,821 $0.00 Strike: $0.89 $0.00
Disclosure

SEC source: 0001829126-25-001254 · ownership.xml · derivative · entry 1

Owens David · CIK 0001916664 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,821

Underlying: Common Stock · 139,821 shares

Expires 2033-06-30

Read SEC document
February 26, 2025 Filed Feb 27, 2025 21:34 UTC
White MarkDirector · President and CEO
GrantStock Option (right to buy) · Derivative 939,597 $0.00 Strike: $0.89 $0.00
Disclosure

SEC source: 0001829126-25-001256 · ownership.xml · derivative · entry 2

White Mark · CIK 0001916493 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,387,024

Underlying: Common Stock · 939,597 shares

Expires 2034-06-30

F1 · derivative.exercise_date: The option vests in three equal annual installments based on the satisfaction of certain performance criteria for each of the annual periods ending June 30, 2024, 2025 and 2026. The performance criteria for the period ending June 30, 2024 were met, resulting in the vesting of options to purchase 313,199 shares.

Read SEC document
February 26, 2025 Filed Feb 27, 2025 21:34 UTC
White MarkDirector · President and CEO
GrantStock Option (right to buy) · Derivative 447,427 $0.00 Strike: $0.89 $0.00
Disclosure

SEC source: 0001829126-25-001256 · ownership.xml · derivative · entry 1

White Mark · CIK 0001916493 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 447,427

Underlying: Common Stock · 447,427 shares

Expires 2033-06-30

Read SEC document
February 04, 2025 Filed Feb 4, 2025 22:05 UTC
Owens DavidDirector · Chief Medical Officer
PurchaseCommon stock 1,000 $2.98 $2,980.00
Disclosure

SEC source: 0001829126-25-000672 · ownership.xml · nonDerivative · entry 1

Owens David · CIK 0001916664 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 154,793

Read SEC document
February 04, 2025 Filed Feb 5, 2025 20:17 UTC
Owens DavidDirector · Chief Medical Officer
PurchaseCommon stock 1,000 $3.10 $3,100.00
Disclosure

SEC source: 0001829126-25-000724 · ownership.xml · nonDerivative · entry 1

Owens David · CIK 0001916664 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 155,793

Read SEC document
January 28, 2025 Filed Jan 29, 2025 22:22 UTC
Owens DavidDirector · Chief Medical Officer
PurchaseCommon stock 1,500 $2.70 $4,050.00
Disclosure

SEC source: 0001829126-25-000542 · ownership.xml · nonDerivative · entry 1

Owens David · CIK 0001916664 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 153,793

Read SEC document
January 23, 2025 Filed Jan 24, 2025 21:55 UTC
Owens DavidDirector · Chief Medical Officer
PurchaseCommon stock 1,000 $2.70 $2,700.00
Disclosure

SEC source: 0001829126-25-000368 · ownership.xml · nonDerivative · entry 2

Owens David · CIK 0001916664 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,293

Read SEC document
January 13, 2025 Filed Jan 24, 2025 21:55 UTC
Owens DavidDirector · Chief Medical Officer
PurchaseCommon stock 2,000 $2.50 $5,000.00
Disclosure

SEC source: 0001829126-25-000368 · ownership.xml · nonDerivative · entry 1

Owens David · CIK 0001916664 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 151,293

Read SEC document
December 20, 2024 Filed Jan 29, 2025 22:26 UTC
Owens DavidDirector · Chief Medical Officer
PurchaseCommon stock 1,000 $2.75 $2,750.00
Disclosure

SEC source: 0001829126-25-000544 · ownership.xml · nonDerivative · entry 1

Owens David · CIK 0001916664 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 149,293

Read SEC document
November 07, 2024 Filed Jan 29, 2025 22:26 UTC
Owens DavidDirector · Chief Medical Officer
GrantStock Option (right to buy) · Derivative 262,500 $0.00 Strike: $0.94 $0.00
Disclosure

SEC source: 0001829126-25-000544 · ownership.xml · derivative · entry 2

Owens David · CIK 0001916664 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 262,500

Underlying: Common Stock · 262,500 shares

Expires 2029-08-26

Read SEC document
November 07, 2024 Filed Feb 10, 2025 18:21 UTC GrantStock Option (right to buy) · Derivative 90,620 $0.00 Strike: $0.66 $0.00
Disclosure

SEC source: 0001829126-25-000849 · ownership.xml · derivative · entry 3

Shelton Carolyn Hamby · CIK 0002053473 · Senior VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,620

Underlying: Common Stock · 90,620 shares

Expires 2029-09-25

F2 · derivative.exercise_date: The reporting person was granted an option to purchase 90,620 shares of common stock. The option vests in three equal annual installments based on the satisfaction of certain performance criteria for each of the annual periods ending September 16, 2025, 2026 and 2027.

Read SEC document
November 02, 2024 Filed Jan 29, 2025 22:25 UTC
Kazden AlanDirector
PurchaseStock Option (right to buy) · Derivative 262,500 $0.00 Strike: $0.94 $0.00
Disclosure

SEC source: 0001829126-25-000543 · ownership.xml · derivative · entry 1

Kazden Alan · CIK 0001917765 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 262,500

Underlying: Common Stock · 262,500 shares

Expires 2029-08-26

Read SEC document
October 28, 2024 Filed Oct 30, 2024 14:55 UTC
Owens DavidDirector · Chief Medical Officer
PurchaseCommon stock 500 $2.19 $1,095.00
Disclosure

SEC source: 0001829126-24-007091 · ownership.xml · nonDerivative · entry 1

Owens David · CIK 0001916664 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 148,293

Read SEC document
October 14, 2024 Filed Feb 10, 2025 18:21 UTC PurchaseCommon stock 24,000 $0.85 $20,400.00
Disclosure

SEC source: 0001829126-25-000849 · ownership.xml · nonDerivative · entry 1

Shelton Carolyn Hamby · CIK 0002053473 · Senior VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,000

F1 · kind: Represents shares purchased after appointment as Senior Vice President, Quality, Regulatory and Clinical Affairs.

Read SEC document
September 30, 2024 Filed Oct 2, 2024 14:04 UTC Amendment
Elson Marilyn10% owner
GrantCommon Stock 700,000 $0.00 $0.00
Disclosure

SEC source: 0001829126-24-006598 · ownership.xml · nonDerivative · entry 1

Elson Marilyn · CIK 0001916491 · 10% owner

OSSER LEONARD · CIK 0001188354 · Spouse

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,535,244

Read SEC document
September 30, 2024 Filed Oct 2, 2024 18:02 UTC GrantCommon stock 49,838 $0.00 $0.00
Disclosure

SEC source: 0001829126-24-006597 · ownership.xml · nonDerivative · entry 1

Bernhard Leslie · CIK 0001333581 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,838

Read SEC document
September 30, 2024 Filed Oct 2, 2024 18:01 UTC
Hu BenDirector
GrantCommon stock 175,000 $0.00 $0.00
Disclosure

SEC source: 0001829126-24-006596 · ownership.xml · nonDerivative · entry 1

Hu Ben · CIK 0001916504 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 340,636

F1 · balance_after: Includes 336,470 shares held by Mr. Hu, 3,582 shares held jointly by Mr. Hu and Amy Lun Hu, his spouse, and 584 shares held jointly by Mr. Hu and David D. Hu, his son

Read SEC document
September 23, 2024 Filed Sep 25, 2024 17:27 UTC
Elson Marilyn10% owner
GrantCommon Stock 700,000 $0.00 $0.00
Disclosure

SEC source: 0001829126-24-006465 · ownership.xml · nonDerivative · entry 1

Elson Marilyn · CIK 0001916491 · 10% owner

OSSER LEONARD · CIK 0001188354 · Spouse

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,535,244

Read SEC document
August 13, 2024 Filed Aug 15, 2024 20:25 UTC
Owens DavidDirector · Chief Medical Officer
PurchaseCommon stock 1,000 $0.95 $950.00
Disclosure

SEC source: 0001829126-24-005573 · ownership.xml · nonDerivative · entry 1

Owens David · CIK 0001916664 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 147,793

Read SEC document
June 28, 2024 Filed Jul 1, 2024 17:47 UTC
Owens DavidDirector · Chief Medical Officer
PurchaseCommon stock 1,000 $1.75 $1,750.00
Disclosure

SEC source: 0001829126-24-004517 · ownership.xml · nonDerivative · entry 1

Owens David · CIK 0001916664 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 146,793

Read SEC document
June 18, 2024 Filed Jun 21, 2024 15:21 UTC
Owens DavidDirector · Chief Medical Officer
PurchaseCommon stock 1,619 $0.71 $1,149.49
Disclosure

SEC source: 0001829126-24-004353 · ownership.xml · nonDerivative · entry 1

Owens David · CIK 0001916664 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 145,793

Read SEC document
June 10, 2024 Filed Jun 12, 2024 17:19 UTC
Owens DavidDirector · Chief Medical Officer
PurchaseCommon stock 1,000 $0.62 $620.00
Disclosure

SEC source: 0001829126-24-004108 · ownership.xml · nonDerivative · entry 2

Owens David · CIK 0001916664 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,174

Read SEC document
June 10, 2024 Filed Jun 12, 2024 17:19 UTC
Owens DavidDirector · Chief Medical Officer
PurchaseCommon stock 2,000 $0.65 $1,300.00
Disclosure

SEC source: 0001829126-24-004108 · ownership.xml · nonDerivative · entry 1

Owens David · CIK 0001916664 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 143,174

Read SEC document
September 28, 2022 Filed Sep 29, 2022 12:30 UTC
Elson MarilynMs. Elson serves as CFO · 10% owner
PurchaseCommon Stock 9,500 $1.12 $10,640.00
Disclosure

SEC source: 0001829126-22-017254 · ownership.xml · nonDerivative · entry 1

Elson Marilyn · CIK 0001916491 · Ms. Elson serves as CFO · 10% owner

OSSER LEONARD · CIK 0001188354 · Spouse

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · shares owned jointly by reporting person and by spouse

Disclosed balance after: 835,244

F1 · ownership.nature: Includes shares that Reporting Person owns with spouse Leonard Osser and for which Reporting Person has shared voting and dispositive power with spouse. Form 4 filed as joint ownership filing

Read SEC document
September 28, 2022 Filed Oct 5, 2023 12:07 UTC
Elson MarilynMs. Elson serves as CFO · 10% owner
PurchaseCommon stock warrants · Derivative 9,500 $0.40 Strike: $4.15 $3,800.00
Disclosure

SEC source: 0001829126-23-006447 · ownership.xml · derivative · entry 1

Elson Marilyn · CIK 0001916491 · Ms. Elson serves as CFO · 10% owner

OSSER LEONARD · CIK 0001188354 · Spouse

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,500

Underlying: Common Stock · 9,500 shares

Expires 2025-09-19

Read SEC document
September 28, 2022 Filed Sep 25, 2024 17:26 UTC Amendment
Elson Marilyn10% owner
PurchaseCommon stock warrants · Derivative 36,000 $0.40 Strike: $4.15 $14,400.00
Disclosure

SEC source: 0001829126-24-006464 · ownership.xml · derivative · entry 1

Elson Marilyn · CIK 0001916491 · 10% owner

OSSER LEONARD · CIK 0001188354 · Spouse

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 136,000

Underlying: Common Stock · 36,000 shares

Expires 2025-09-19

Read SEC document
September 16, 2022 Filed Sep 20, 2022 14:29 UTC
Elson MarilynMs. Elson serves as CFO · 10% owner
PurchaseCommon stock warrants · Derivative 100,000 $0.40 Strike: $4.15 $40,000.00
Disclosure

SEC source: 0001829126-22-017010 · ownership.xml · derivative · entry 2

Elson Marilyn · CIK 0001916491 · Ms. Elson serves as CFO · 10% owner

OSSER LEONARD · CIK 0001188354 · Spouse

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2025-09-19

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.